Sun Pharmaceutical Industries Ltd

News across the web »
Interact & exchange stock tips & market info »

Web Messenger

Platinum Member

107814 Followers

Web Messenger

Platinum Member

107814 Followers

MMB Messenger

Platinum Member

112422 Followers

Related News »
Mumbai, May 24, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA ...
May 24, 2012 at 11:40 | Source: Phramalive.com
Mumbai: Drug maker Sun Pharmaceutical Industries Ltd’s Israeli subsidiary Taro Pharmaceutical Industries Ltd almost doubled its net profit to $47.3 million in the January-March quarter. The company had posted a net profit of $25.7 million in the year-ago period.
May 25, 2012 at 09:16 | Source: Livemint.com
Mumbai, May 18, 2012: Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) announced that the USFDA has granted its subsidiary an approval for its Abbreviated New Drug Application (ANDA ...
May 18, 2012 at 11:54 | Source: Phramalive.com
The new fiscal year end was effectuated to align Taro's fiscal reporting period and its annual budget planning with that of its major shareholder, Sun Pharmaceutical Industries Ltd. ("Sun Pharma," Reuters: SUN.BO, Bloomberg: SUNP IN, NSE ...
May 24, 2012 at 20:22 | Source: Marketwatch
Astelin® is a registered trademark of Medpointe Pharm HLC (Medpointe) The Sun Pharmaceutical Industries Ltd stock was trading at Rs.567, down by Rs.4.35 or 0.76%. The stock hit an intraday high of Rs.575.25 and low of Rs.561.55. The total ...
May 24, 2012 at 07:58 | Source: equitybulls.com
(RTTNews) - Taro Pharmaceutical Industries Ltd. (TARO: News ) Thursday reported an increase in profit for the first quarter, as revenue surged and margins improved. Net income attributable to Taro improved to $47.3 million or $1.06 per share, compared to $ ...
May 24, 2012 at 22:17 | Source: RTT News
Four Indian drug makers — Dr Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Aurobindo Pharma Ltd — have received approval from the US Food and Drug Administration (USFDA) to launch a low-cost version of ...
May 18, 2012 at 19:25 | Source: Business Standard
Teva, Mylan Inc. (NYSE: MYL), Apotex Corporation, Roxane Laboratories Inc. of the US, India's Sun Pharmaceutical Industries Ltd. (BSE: 524715) Aurobindo Pharma Ltd. (BSE: 524804) and Torrent Pharmaceuticals, obtained marketing approval for 75 milligram ...
May 20, 2012 at 09:36 | Source: Globes - Israel Business Arena
Four Indian drug makers get US nod to launch generic version of Plavix 19-MAY-12 Four Indian drug makers — Dr Reddy’s Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Torrent Pharmaceuticals Ltd and Aurobindo Pharma Ltd — have received approval ...
May 19, 2012 at 12:50 | Source: Business Standard
The press release "Taro Special Committee Continues to Evaluate Sun Pharma's Proposal to Acquire Taro ... the notice that the release had been issued in error. Taro Pharmaceutical Industries Ltd. (TARO) said the release was a draft internal press release.
May 11, 2012 at 21:42 | Source: 4-traders (press release)